PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,992 | +1.6% | 2,613 | +28.9% | 0.00% | 0.0% |
| Q2 2023 | $26,574 | +17.3% | 2,027 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $22,662 | +22.4% | 2,027 | -7.7% | 0.00% | 0.0% |
| Q4 2022 | $18,512 | -49.4% | 2,196 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $36,585 | +13.2% | 2,196 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $32,325 | -27.6% | 2,196 | +22.0% | 0.00% | -50.0% |
| Q1 2022 | $44,658 | -81.7% | 1,800 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $244,630 | -10.9% | 7,628 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $274,455 | -18.4% | 7,628 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $336,547 | +97.5% | 7,628 | +104.8% | 0.01% | +66.7% |
| Q1 2021 | $170,382 | -33.7% | 3,725 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $257,100 | – | 3,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |